NO843563L - Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid - Google Patents
Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tidInfo
- Publication number
- NO843563L NO843563L NO843563A NO843563A NO843563L NO 843563 L NO843563 L NO 843563L NO 843563 A NO843563 A NO 843563A NO 843563 A NO843563 A NO 843563A NO 843563 L NO843563 L NO 843563L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- long time
- active ingredients
- pharmaceutical preparations
- high content
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU83245A HU187215B (en) | 1983-01-26 | 1983-01-26 | Method for producing pharmaceutical product of high actor content and prolonged effect |
Publications (1)
Publication Number | Publication Date |
---|---|
NO843563L true NO843563L (no) | 1984-09-07 |
Family
ID=10948692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO843563A NO843563L (no) | 1983-01-26 | 1984-09-07 | Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid |
Country Status (15)
Country | Link |
---|---|
US (1) | US4748023A (no) |
JP (1) | JPS60500213A (no) |
BE (1) | BE898888A (no) |
CH (1) | CH661659A5 (no) |
DE (1) | DE3490030T1 (no) |
DK (1) | DK457984A (no) |
FI (1) | FI843773L (no) |
FR (1) | FR2559389B1 (no) |
GB (1) | GB2143734B (no) |
HU (1) | HU187215B (no) |
NL (1) | NL8420009A (no) |
NO (1) | NO843563L (no) |
SE (1) | SE458092B (no) |
SU (1) | SU1535369A3 (no) |
WO (1) | WO1984002843A1 (no) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3532692A1 (de) * | 1985-09-13 | 1987-03-19 | Boehringer Mannheim Gmbh | Verfahren zum herstellen von tabletten aus pellets |
NZ217813A (en) | 1985-10-21 | 1991-01-29 | Grace W R & Co | Dipeptides and process for their preparation using an enzyme coupling agent |
US4892742A (en) * | 1985-11-18 | 1990-01-09 | Hoffmann-La Roche Inc. | Controlled release compositions with zero order release |
WO1987006828A1 (en) * | 1986-05-16 | 1987-11-19 | The State Of Victoria | Biocompatible implants |
US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
US5624683A (en) * | 1986-08-06 | 1997-04-29 | Eisai Co., Ltd. | Sustained-release multi-granule tablet |
WO1988002629A1 (en) * | 1986-10-16 | 1988-04-21 | American Health Products Corporation | 2',3'-didesoxyadenosine composition |
GB8628728D0 (en) * | 1986-12-02 | 1987-01-07 | Euro Celtique Sa | Spheroids |
GB8710965D0 (en) * | 1987-05-08 | 1987-06-10 | Smith Kline French Lab | Pharmaceutical compositions |
FR2624732B1 (fr) * | 1987-12-21 | 1991-02-15 | Synthelabo | Formulation pharmaceutique a liberation prolongee |
US4904474A (en) * | 1988-01-25 | 1990-02-27 | Alza Corporation | Delivery of drug to colon by oral disage form |
US5268182A (en) * | 1988-06-24 | 1993-12-07 | Abbott Laboratories | Sustained-release drug dosage units of terazosin |
US4938968A (en) * | 1988-07-26 | 1990-07-03 | Norjec Development Associates, Inc. | Controlled release indomethacin |
JP2514078B2 (ja) * | 1988-08-22 | 1996-07-10 | エスエス製薬株式会社 | 圧縮成型製剤 |
HU201869B (en) * | 1988-12-30 | 1991-01-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing microcapsules of quick dissolving active component |
JP3011752B2 (ja) * | 1990-10-23 | 2000-02-21 | フロイント産業株式会社 | 徐放性製剤およびその製造方法 |
US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
AU1193092A (en) * | 1992-01-10 | 1993-08-03 | Obschestvo S Ogranichennoi Otvetstvennostju Meditsinsky Nauchno-Proizvodstvenny Komplex Biotiki | Granulated pharmaceutical composition and method of obtaining it |
US5422122A (en) * | 1992-08-04 | 1995-06-06 | Eurand America, Incorporated | Controlled release potassium chloride tablet |
DE4319649A1 (de) * | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
AU5135898A (en) * | 1996-12-03 | 1998-06-29 | Schering-Plough Kabushiki Kaisha | Controlled release matrix tablet and method for its preparation |
US7179486B1 (en) * | 1997-04-01 | 2007-02-20 | Nostrum Pharmaceuticals, Inc. | Process for preparing sustained release tablets |
HU221435B (en) * | 1998-02-20 | 2002-10-28 | Egyt Gyogyszervegyeszeti Gyar | Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production |
AU783656B2 (en) | 1999-09-02 | 2005-11-24 | Nostrum Pharmaceuticals, Inc. | Controlled release oral dosage suitable for oral administration |
RU2203042C2 (ru) | 2000-11-28 | 2003-04-27 | Комиссарова Ирина Алексеевна | Фармацевтическая композиция и способ ее получения |
WO2002043710A1 (fr) * | 2000-11-28 | 2002-06-06 | Irina Alekseevna Komissarova | Composition pharmaceutique, son application et procede de fabrication |
FR2822834B1 (fr) * | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
US20080058424A1 (en) * | 2002-05-23 | 2008-03-06 | Cephalon, Inc. | Novel pharmaceutical formulations of modafinil |
US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
US6780437B2 (en) * | 2001-10-23 | 2004-08-24 | Upsher-Smith Laboratories, Inc. | Coated potassium chloride granules and tablets |
US20030104052A1 (en) * | 2001-10-25 | 2003-06-05 | Bret Berner | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
US20030152622A1 (en) * | 2001-10-25 | 2003-08-14 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral diuretic |
ATE407674T1 (de) * | 2002-04-09 | 2008-09-15 | Flamel Tech Sa | Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin |
ATE419840T1 (de) | 2002-04-09 | 2009-01-15 | Flamel Tech Sa | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
FR2842735B1 (fr) * | 2002-07-26 | 2006-01-06 | Flamel Tech Sa | Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os |
FR2842736B1 (fr) | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s) |
FR2843117B1 (fr) * | 2002-07-30 | 2004-10-15 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques |
US20040116532A1 (en) * | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
US7538094B2 (en) * | 2002-09-19 | 2009-05-26 | Three Rivers Pharmacueticals, Llc | Composition containing ribavirin and use thereof |
JP2006521366A (ja) * | 2003-03-28 | 2006-09-21 | シグモイド・バイオテクノロジーズ・リミテッド | シームレスマイクロカプセルを含む固形経口剤形 |
DE10315640A1 (de) * | 2003-04-04 | 2004-10-14 | Ignatov, Konstantin | Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung |
US7632521B2 (en) * | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
FR2860516B1 (fr) * | 2003-10-03 | 2006-01-13 | Flamel Tech Sa | Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
FR2862536B1 (fr) * | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques |
AU2005204016B2 (en) * | 2004-01-06 | 2008-05-22 | Panacea Biotec Ltd. | Non-disintegrating oral solid composition of high dose of water soluble drugs |
EP1802287A2 (en) * | 2004-09-27 | 2007-07-04 | Sigmoid Biotechnologies Limited | Minicapsule formulations |
US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
NZ555693A (en) * | 2004-12-27 | 2010-10-29 | Eisai R&D Man Co Ltd | Matrix type sustained-release preparation containing donepezil |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
US20060205682A1 (en) * | 2005-02-25 | 2006-09-14 | Roberts Richard H | Antibiotic and combinations of antibiotic and symptomatic relief agent formulations |
FR2885526B1 (fr) * | 2005-05-13 | 2007-07-27 | Flamel Technologies Sa | Medicament oral a base d'inhibiteur de pompe a protons |
US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
JP2010523554A (ja) | 2007-04-04 | 2010-07-15 | シグモイド・ファーマ・リミテッド | タクロリムスの医薬組成物 |
US8951570B2 (en) * | 2007-04-26 | 2015-02-10 | Sigmoid Pharma Limited | Manufacture of multiple minicapsules |
EP2063875A2 (en) * | 2007-05-01 | 2009-06-03 | Sigmoid Pharma Limited | Combination pharmaceutical compositions |
US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
GB2483815B (en) | 2009-05-18 | 2013-12-25 | Sigmoid Pharma Ltd | Composition comprising oil drops |
CN107582526A (zh) | 2009-08-12 | 2018-01-16 | 希格默伊德药业有限公司 | 包含聚合物基质和油相的免疫调节组合物 |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
CA2902911C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
AU2015341695B2 (en) | 2014-11-07 | 2021-07-08 | Sublimity Therapeutics Limited | Compositions comprising cyclosporin |
US10363288B2 (en) | 2015-01-14 | 2019-07-30 | National Jewish Health | Insulin mimotopes and methods of using the same |
US20180116988A1 (en) * | 2015-05-28 | 2018-05-03 | The Regents Of The University Of Colorado A Body Corporate | Methods of preventing and treating autoimmunity |
US10272327B2 (en) * | 2017-07-13 | 2019-04-30 | Performance Designed Products Llc | Detachable joystick for video game controller |
USD890846S1 (en) | 2017-08-07 | 2020-07-21 | Performance Designed Products Llc | Video game controller |
US11052060B2 (en) | 2018-02-12 | 2021-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Compounds and methods for treating autoimmunity |
US11013707B2 (en) | 2018-03-23 | 2021-05-25 | The Regents Of The University Of Colorado, A Body Corporate | Administration of oral methyldopa |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
USD1034816S1 (en) | 2022-03-07 | 2024-07-09 | Performance Designed Products Llc | Video game controller |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2996431A (en) * | 1953-12-16 | 1961-08-15 | Barry Richard Henry | Friable tablet and process for manufacturing same |
US2853420A (en) * | 1956-01-25 | 1958-09-23 | Lowey Hans | Ethyl cellulose coatings for shaped medicinal preparations |
US3155590A (en) * | 1962-08-02 | 1964-11-03 | Ncr Co | Encapsulation process and its product |
US3341416A (en) * | 1963-12-11 | 1967-09-12 | Ncr Co | Encapsulation of aspirin in ethylcellulose and its product |
US3488418A (en) * | 1965-11-18 | 1970-01-06 | Sterling Drug Inc | Sustained relief analgesic composition |
FR5788M (no) * | 1965-11-18 | 1968-03-18 | ||
US3557279A (en) * | 1969-06-12 | 1971-01-19 | Merck & Co Inc | Microencapsulation form of an anti-inflammatory drug |
US3703576A (en) * | 1969-08-08 | 1972-11-21 | Fuji Photo Film Co Ltd | Method of producing micro-capsules enclosing acetylsalicylic acid therein |
DE2200778B2 (de) * | 1971-01-13 | 1974-04-18 | Sandoz Ag, Basel (Schweiz) | Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen |
US3909444A (en) * | 1971-08-05 | 1975-09-30 | Ncr Co | Microcapsule |
JPS523342B2 (no) * | 1972-01-26 | 1977-01-27 | ||
FR2183546B1 (no) * | 1972-05-10 | 1975-06-20 | Servier Lab | |
GB1403584A (en) * | 1972-05-19 | 1975-08-28 | Beecham Group Ltd | Control medicaments |
JPS5438164B2 (no) * | 1972-05-29 | 1979-11-19 | ||
BE791458A (fr) * | 1972-07-31 | 1973-05-16 | Merck & Co Inc | Produit microencapsule |
FR2236483B1 (no) * | 1973-07-12 | 1976-11-12 | Choay Sa | |
US4113816A (en) * | 1973-07-12 | 1978-09-12 | Choay S.A. | Process for the manufacture of layered tablets incorporating controlled-release microcapsules |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
JPS603286B2 (ja) * | 1977-03-03 | 1985-01-26 | 日本化薬株式会社 | 定速溶出性製剤 |
US4308251A (en) * | 1980-01-11 | 1981-12-29 | Boots Pharmaceuticals, Inc. | Controlled release formulations of orally-active medicaments |
CA1165241A (en) * | 1980-05-06 | 1984-04-10 | Bristol-Myers Squibb Company | Sustained release theophylline tablet having reduced bulk |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
-
1983
- 1983-01-26 HU HU83245A patent/HU187215B/hu not_active IP Right Cessation
-
1984
- 1984-01-25 JP JP59500684A patent/JPS60500213A/ja active Pending
- 1984-01-25 GB GB08423339A patent/GB2143734B/en not_active Expired
- 1984-01-25 NL NL8420009A patent/NL8420009A/nl not_active Application Discontinuation
- 1984-01-25 CH CH4717/84A patent/CH661659A5/de not_active IP Right Cessation
- 1984-01-25 DE DE19843490030 patent/DE3490030T1/de not_active Withdrawn
- 1984-01-25 US US06/644,835 patent/US4748023A/en not_active Expired - Fee Related
- 1984-01-25 WO PCT/HU1984/000006 patent/WO1984002843A1/en active Application Filing
- 1984-02-10 FR FR8402050A patent/FR2559389B1/fr not_active Expired
- 1984-02-13 BE BE1/10957A patent/BE898888A/fr not_active IP Right Cessation
- 1984-09-07 NO NO843563A patent/NO843563L/no unknown
- 1984-09-21 SU SU843792253A patent/SU1535369A3/ru active
- 1984-09-25 SE SE8404804A patent/SE458092B/sv not_active IP Right Cessation
- 1984-09-25 DK DK457984A patent/DK457984A/da not_active Application Discontinuation
- 1984-09-26 FI FI843773A patent/FI843773L/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE8404804L (sv) | 1984-09-25 |
NL8420009A (nl) | 1984-12-03 |
FR2559389B1 (fr) | 1986-05-30 |
DE3490030T1 (de) | 1985-02-21 |
FI843773A0 (fi) | 1984-09-26 |
DK457984D0 (da) | 1984-09-25 |
JPS60500213A (ja) | 1985-02-21 |
BE898888A (fr) | 1984-08-13 |
DK457984A (da) | 1984-09-25 |
FR2559389A1 (fr) | 1985-08-16 |
SU1535369A3 (ru) | 1990-01-07 |
FI843773L (fi) | 1984-09-26 |
GB8423339D0 (en) | 1984-10-17 |
CH661659A5 (de) | 1987-08-14 |
WO1984002843A1 (en) | 1984-08-02 |
GB2143734A (en) | 1985-02-20 |
GB2143734B (en) | 1986-07-30 |
HU187215B (en) | 1985-11-28 |
US4748023A (en) | 1988-05-31 |
SE458092B (sv) | 1989-02-27 |
SE8404804D0 (sv) | 1984-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO843563L (no) | Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid | |
DE3372845D1 (en) | Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof | |
HUT51617A (en) | Process for producing oxadiazole derivatives and pharmaceutical preparations containing these compounds as active substance | |
IL60510A (en) | Derivatives of n-(mercaptoalkylcarbonyl)glycine,processes for their preparation and pharmaceutical compositions containing them | |
HU179793B (en) | Process for preparing 4-amino-5-sulphonyl-o-anisamide derivatives and pharmaceutical preparations containing such compounds as active materials | |
PT71724B (en) | Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vasodilator effect and of pharmaceutical compositions containing them | |
IL68267A (en) | Derivatives of cycloalka(c),pyrrolcarboxylic acids,process for their preparation,and pharmaceutical compositions containing them | |
PT86236A (en) | Process for the preparation of catechol derivatives and of pharmaceutical compositions containing them | |
HUT37424A (en) | Process for preparing new 5-pyridyl-1,3-thiazoie derivatives and pharmaceutical compositions containing thereof as active substances | |
DE3366393D1 (en) | Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same | |
AR243515A1 (es) | Un procedimiento para la obtencion de derivados de tiazol activos sobre el sistema colinergico. | |
HU173465B (hu) | Sposob poluchenija proizvodnykh tieno-benzoksepinil-uksusnojj kisloty i farmacevticheskikh preparatov soderzhahhikh takie soedineija kak aktivnye behhestva | |
NO172230C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser, samt forbindelser som er mellomprodukter ved fremgangsmaaten | |
AU583255B2 (en) | New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions | |
NO159528C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater. | |
DE2860490D1 (en) | 4-spectinomycylamin and its physiologically acceptable salts, method of preparation and pharmaceutical products containing these substances | |
AU586410B2 (en) | New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions | |
HUT41750A (en) | Process for preparing 2-hydroxy-4h-3,1-benzazin-4-one derivatives, pharmaceutical compositions containing thereof as active ingredients and intermediers thereof | |
CS189028B2 (en) | Fundicide and bactericide preparations for the suppression of maladies and method of preparation the active substances | |
NO843377L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater | |
HUT37036A (en) | Process for preparing pharmaceutical compositions with retarded release of the active substance | |
DK164865C (da) | Silibininderivater, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende silibininderivaterne | |
NO163617C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater. | |
CY1228A (en) | Bronchospasmolytically active compounds,processes for their preparation,pharmaceutical preparations containing them and their medicinal use | |
PT76951A (en) | Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them |